These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8834466)

  • 1. Human T-lymphotropic virus type I excretion and specific antibody response in paired saliva and cervicovaginal secretions.
    Belec L; Jean Georges A; Hallouin MC; Si Mohamed A; Morand-Joubert L; Georges-Courbot MC
    AIDS Res Hum Retroviruses; 1996 Jan; 12(2):157-167. PubMed ID: 8834466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervicovaginal synthesis of IgG antibodies to the immunodominant 175-199 domain of the surface glycoprotein gp46 of human T-cell leukemia virus type I.
    Bélec L; Georges-Courbot MC; Georges A; Mohamed AS; Londos-Gagliardi D; Hallouin MC; Hocini H; Guillemain B
    J Med Virol; 1996 Sep; 50(1):42-9. PubMed ID: 8890040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a high sensitive immunoenzymatic assay to establish the origin of immunoglobulins in female genital secretions.
    Bard E; Riethmuller D; Biichlé S; Meillet D; Prétet JL; Mougin C; Seillès E
    J Immunoassay Immunochem; 2002; 23(2):145-62. PubMed ID: 12033640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection.
    Bélec L; Dupré T; Prazuck T; Tévi-Bénissan C; Kanga JM; Pathey O; Lu XS; Pillot J
    J Infect Dis; 1995 Sep; 172(3):691-7. PubMed ID: 7658060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.
    Bélec L; Tévi-Bénissan C; Dupré T; Mohamed AS; Prazuck T; Gilquin J; Kanga JM; Pillot J
    J Clin Immunol; 1996 Jan; 16(1):12-20. PubMed ID: 8926281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.
    Desgranges C; Souche S; Vernant JC; Smadja D; Vahlne A; Horal P
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):163-73. PubMed ID: 8198868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal humoral immune response to hepatitis C virus E1/E2 surface glycoproteins and HCV shedding in saliva and cervicovaginal fluids from chronically HCV-infected patients.
    Bélec L; Legoff J; Si-Mohamed A; Bloch F; Mbopi Keou FX; Becquart P; Matta M; Prazuck T; Petite JP; Gutmann L; Payan C
    J Hepatol; 2003 Jun; 38(6):833-42. PubMed ID: 12763378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects.
    Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
    AIDS Res Hum Retroviruses; 1999 Oct; 15(15):1365-76. PubMed ID: 10515152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-lymphotropic virus type I (HTLV-I)-specific antibodies and cell-free RNA in crevicular fluid-rich saliva from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy.
    Soto-Ramirez LE; Garcia-Vallejo F; Renjifo B; Vergara A; Borrero I; Marlink R; Essex M
    Viral Immunol; 1995; 8(3):141-50. PubMed ID: 8833267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women.
    Lu XS; Bélec L; Pillot J
    J Infect Dis; 1993 May; 167(5):1189-92. PubMed ID: 8486953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk papillomavirus infection is associated with altered antibody responses in genital tract: non-specific responses in HPV infection.
    Bard E; Riethmuller D; Meillet D; Prétet JL; Schaal JP; Mougin C; Seillès E
    Viral Immunol; 2004; 17(3):381-9. PubMed ID: 15357904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.
    Lal RB; Buckner C; Khabbaz RF; Kaplan JE; Reyes G; Hadlock K; Lipka J; Foung SK; Chan L; Coligan JE
    Clin Immunol Immunopathol; 1993 Apr; 67(1):40-9. PubMed ID: 7680300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity.
    Black KP; Fultz PN; Girard M; Jackson S
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1273-82. PubMed ID: 9339844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p24 protein of a human T-lymphotropic virus type-I (HTLV-I) producing cell line (TCL-Kan) reacts with some normal pregnant women's sera.
    Ando Y; Hashimoto H; Kakimoto K; Tanigawa T; Moriyama I; Ichijo M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1251-5. PubMed ID: 2212826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing activity and antibody reactivity toward immunogenic regions of the human T cell leukemia virus type I surface glycoprotein in sera of infected patients with different clinical states.
    Astier-Gin T; Portail JP; Londos-Gagliardi D; Moynet D; Blanchard S; Dalibart R; Pouliquen JF; Georges-Courbot MC; Hajjar C; Sainte-Foie S; Guillemain B
    J Infect Dis; 1997 Mar; 175(3):716-9. PubMed ID: 9041352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological and virological evaluation of human T-lymphotropic virus type 1 infection in family groups from Tumaco, Colombia.
    Domínguez MC; Salcedo M; García-Vallejo F
    Biomedica; 2015; 35(3):337-46. PubMed ID: 26849695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the cervicovaginal environment in asymptomatic Human T-cell lymphotropic virus type 1 infected women.
    Firmino AA; Martins ALL; Gois LL; Paixão TS; Batista EDS; Galvão-Castro B; Grassi MFR
    Braz J Infect Dis; 2019; 23(1):27-33. PubMed ID: 30849331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the time of HTLV-I infection following mother-to-child transmission in a breast-feeding population in Jamaica.
    Furnia A; Lal R; Maloney E; Wiktor S; Pate E; Rudolph D; Waters D; Blattner W; Manns A
    J Med Virol; 1999 Dec; 59(4):541-6. PubMed ID: 10534739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin classes of antibody for human T-lymphotropic virus type-I (HTLV-I) in healthy donors and HTLV-I-associated disorders.
    Kamihira S; Sohda H; Oyakawa N; Moriuti Y; Momita S; Ikeda S; Yamada Y; Ichimaru M; Kinosita K; Okuda H
    Vox Sang; 1989; 56(3):168-73. PubMed ID: 2728394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the Complement System in the Lower Genital Tract During Pregnancy and Delivery.
    Livson S; Jarva H; Kalliala I; Lokki AI; Heikkinen-Eloranta J; Nieminen P; Meri S
    Front Immunol; 2020; 11():563073. PubMed ID: 33505390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.